Profile
David Barrett currently works at Mitobridge, Inc., as Division Head & President from 2022 and o2h Ltd, as Senior Venture Partner.
Dr. Barrett also formerly worked at Astellas Pharma, Inc., as Executive Director from 2020 to 2022 and Nanna Therapeutics Ltd., as President in 2022.
Dr. Barrett received his undergraduate degree in 1986 and doctorate degree in 1986 from Newcastle University.
David Barrett active positions
| Companies | Position | Start |
|---|---|---|
Mitobridge, Inc.
Mitobridge, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company | President | 01/05/2022 |
Former positions of David Barrett
| Companies | Position | End |
|---|---|---|
Nanna Therapeutics Ltd.
Nanna Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops and sells pharmaceutical products | President | 01/05/2022 |
| ASTELLAS PHARMA INC. | Corporate Officer/Principal | 01/01/2022 |
o2h Ltd
o2h Ltd Investment ManagersFinance O2h is an active manager which invests in EIS & SEIS companies located in the UK. The firm targets companies operating in the fields of pharmaceuticals, biotechnology, novel drug discovery, AI technologies, digital therapeutics and enabling services. It provides financing for seed and early stage capital requirements. | Private Equity Investor | - |
Training of David Barrett
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Newcastle University
Newcastle University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Astellas Pharma, Inc.
Astellas Pharma, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceuticals and related medical products | Health Technology |
Mitobridge, Inc.
Mitobridge, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company | Health Technology |
o2h Ltd
o2h Ltd Investment ManagersFinance O2h is an active manager which invests in EIS & SEIS companies located in the UK. The firm targets companies operating in the fields of pharmaceuticals, biotechnology, novel drug discovery, AI technologies, digital therapeutics and enabling services. It provides financing for seed and early stage capital requirements. | Finance |
Nanna Therapeutics Ltd.
Nanna Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops and sells pharmaceutical products | Health Technology |
- Stock Market
- Insiders
- David Barrett
















